Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine for Hospitalized COVID-19 in Vietnam
NCT04328493Phase 2Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of chloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Oxford University Clinical Research Unit. Primary endpoint: Viral clearance time up to 56 days. Started Apr 2020; status: completed.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04328493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328493.